Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Universiteit Utrecht - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013340
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master’s, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainability, health and life sciences; economics, management and organization, philosophy and religious sciences, health and animal; languages, literature and communication; law, economics and governance; media, arts, culture and history, mathematics and information sciences; natural sciences; social and behavioural sciences, and others. Universiteit Utrecht comprise centers for academic affairs; general affairs; communications and marketing; human resources; finances, control and administration; corporate real estate and campus; university facilities services; information and technology services; centre for science communication and culture. It collaborates with research institutes, businesses and social institutions, and other universities. Universiteit Utrecht is headquartered in Utrecht, the Netherlands.

Universiteit Utrecht – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Universiteit Utrecht, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Universiteit Utrecht, Medical Devices Deals, 2011 to YTD 2017 9
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cristal Therapeutics Raises USD14 Million in Venture Financing 11
Cristal Therapeutics Raises More than USD7.5 Million in Venture Financing 13
Prothix Raises USD0.1 Million Funding 15
Partnerships 16
Beijing Genomics Enters Into Co-Development Agreement With Utrecht University And UMC Utrecht 16
Universiteit Utrecht – Key Competitors 17
Universiteit Utrecht – Key Employees 18
Universiteit Utrecht – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Universiteit Utrecht, Pharmaceuticals & Healthcare, Key Facts 2
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Universiteit Utrecht, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Universiteit Utrecht, Deals By Therapy Area, 2011 to YTD 2017 8
Universiteit Utrecht, Medical Devices Deals, 2011 to YTD 2017 9
Universiteit Utrecht, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cristal Therapeutics Raises USD14 Million in Venture Financing 11
Cristal Therapeutics Raises More than USD7.5 Million in Venture Financing 13
Prothix Raises USD0.1 Million Funding 15
Beijing Genomics Enters Into Co-Development Agreement With Utrecht University And UMC Utrecht 16
Universiteit Utrecht, Key Competitors 17
Universiteit Utrecht, Key Employees 18
Universiteit Utrecht, Subsidiaries 19

★海外企業調査レポート[Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oil States International, Inc. (OIS)-石油・ガス分野:企業M&A・提携分析
    Summary Oil States International, Inc. (Oil States) is an oilfield services company. It offers specialty products and services to oil and natural gas companies. The company’s product portfolio includes subsea equipment and offshore vessel, rig equipment, flexible bearings, connection systems, subsea …
  • L-3 Communications Oceania Limited:企業の戦略・SWOT・財務情報
    L-3 Communications Oceania Limited - Strategy, SWOT and Corporate Finance Report Summary L-3 Communications Oceania Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Hawkins Inc (HWKN):企業の財務・戦略的SWOT分析
    Hawkins Inc (HWKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Stamps.com Inc. (STMP):企業の財務・戦略的SWOT分析
    Stamps.com Inc. (STMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務分析
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Arthrex Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company that designs and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and wr …
  • Slovenske elektrarne, a.s.-エネルギー分野:企業M&A・提携分析
    Summary Slovenske elektrarne, a.s. (Slovenske), is an electric utility company that generates, distributes and trades electricity. It also generates and markets heat and offers ancillary services to the power industry. The company generates electricity through various resources such as conventional …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Excelsior Capital Ltd (ECL):企業の財務・戦略的SWOT分析
    Excelsior Capital Ltd (ECL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • DH Private Equity Partners:企業の戦略・SWOT・財務分析
    DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report Summary DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kautex Textron GmbH & Co. K.G.:企業の戦略・SWOT・財務情報
    Kautex Textron GmbH & Co. K.G. - Strategy, SWOT and Corporate Finance Report Summary Kautex Textron GmbH & Co. K.G. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • S&T Bancorp Inc:企業の戦略・SWOT・財務情報
    S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Guangzhou Wondfo Biotech Co Ltd (300482):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Patterson-UTI Energy, Inc.:企業の戦略・SWOT・財務情報
    Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Patterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Southwestern Energy Co (SWN):石油・ガス:M&Aディール及び事業提携情報
    Summary Southwestern Energy Co (Southwestern Energy) is an oil and gas company that carries out exploration, development and production of natural gas and crude oil. The company operates through its divisions such as exploration, drilling, completion, production and midstream. Its midstream business …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆